Manufacturer/Distributor:
Notice of Compliance (yyyy/mm/dd):
Date Marketed in Canada (yyyy/mm/dd):
Presentation:
Implant: 0.7 mg. DIN: 02363445
Further Information:
For treatment of macular edema following central retinal vein occlusion. For treatment of non-infectious uveitis affecting the posterior segment of the eye.